Bone scanning: radionuclidic reaction mechanisms.
One of the major successes of nuclear medicine in recent years has been the clinical utility of the 99mTc-labeled bone-imaging agents. This article is concerned with the evidence available for the mechanisms by which these and other such radiopharmaceuticals localize at sites in the skeleton.
D000818:Animals; D001842:Bone and Bones / Q000378:metabolism*; D003094:Collagen / Q000378:metabolism; D011756:Diphosphates / Q000378:metabolism; D005461:Fluorine / Q000378:metabolism; D005708:Gallium / Q000378:metabolism; D006882:Hydroxyapatites / Q000378:metabolism; D007501:Iron / Q000378:metabolism; D008673:Metals, Alkaline Earth / Q000378:metabolism; D008674:Metals, Rare Earth / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D011817:Rabbits; D011877:Radionuclide Imaging; D051381:Rats; D013667:Technetium / Q000378:metabolism
D011756:Diphosphates; D006882:Hydroxyapatites; D008673:Metals, Alkaline Earth; D008674:Metals, Rare Earth; D009943:Organophosphorus Compounds; D010710:Phosphates; D005461:Fluorine; D013667:Technetium; D003094:Collagen; D005708:Gallium; D007501:Iron; D010744:Phosphoric Monoester Hydrolases